medigraphic.com

2015, Número 4

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2015; 53 (4)


Factores de riesgo asociados a hemotransfusión alogénica en pacientes con cirugía de cadera

Durán-Nah JJ, Pastelín-Ruiz SE, Miam-Viana EJ

Idioma: Español
Referencias bibliográficas: 29
Paginas: 406-413
Archivo PDF: 325.59 Kb.


RESUMEN

Introducción: el objetivo es identificar los factores de riesgo asociados a la hemotransfusión alogénica en pacientes con cirugía de cadera realizada en un hospital general citadino, durante 2008 y 2009.
Métodos: fueron considerados como casos 118 pacientes que recibieron sangre alogénica en el pre, el trans o en el postquirúrgico inmediato, y como controles 138 pacientes que tuvieron el mismo tipo de cirugía, pero no fueron hemotransfundidos. La relación entre variables se investigó utilizando un modelo de regresión logística del que se obtuvieron la razón de momios (RM) y los intervalos de confianza (IC) de 95 %.
Resultados: se identificaron como factores de riesgo: el sangrado transquirúrgico ≥ 400 ml (frente a ‹ 400 ml, RM 5.68, IC 95 % 2.5 a 12.9, p = 0.007) y la concentración prequirúrgica de hemoglobina ‹ 11 g/dL (frente a ≥ 11 g/dL, RM 2.86, IC 95 % 1.5 a 5.6; p = 0.001); pero no la duración de la cirugía, el segmento femoral intervenido, la técnica quirúrgica ni la Hb postquirúrgica.
Conclusiones: el sangrado transquirúrgico ≥ 400 ml y la Hb prequirúrgica ‹ 11 g/dL incrementaron el riesgo de hemotransfusión alogénica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014; 54 (10 Pt 2): 2688-95.

  2. Shander A, Javidroozi M, Ozawa S, Hare GMT. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107 (S1): i41-59.

  3. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009; 302 (14); 1573-9.

  4. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am 2014; 96 (23): 1945-51.

  5. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 2014; 96 (4): 272-8.

  6. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013; 28 (8 Suppl): 34-7.

  7. Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, et al.Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am 2014; 96 (4): 279-84.

  8. Jans Ø, Jørgensen C, Kehlet H, Johansson PI. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014; 54 (3):717-26.

  9. Gul A, Sambandam S, Shanbhag V, Morgan G. Transfusion requirements in hip fractures: analysis of predictive factors. Eur J Orthop Surg Traumatol 2007; 17 (1): 71-5.

  10. Rashiq S, Shah M, Chow AK, O´Connor PJ, Finegan BA. Predicting allogeneic blood transfusion use in total joint arthroplasty. Anesth Analg 2004; 99 (4): 1239-44.

  11. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis L. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplastly. J Bone Joint Surg (Am) 2004; 86 (1): 57-61.

  12. Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Aging 2008; 37 (2): 173-8.

  13. Zuckerman JD. Hip fracture. N Engl J Med 1996; 334 (23):1519-25.

  14. Couvret C, Tricoche S, Baud A, Dabo B, Buchet S, Palud M, et al. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates. Anesth Analg 2002; 94 (4):815-23.

  15. Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anesthesia 2012;108 (1):63-71.

  16. Menezes S, Manso T, Seifert I, Rodrigues R, Gil G. Blood loss in total hip/knee replacement surgery. Eur J Anaesth 2011; 28 (Suppl 48 Poster 6AP5-7): 92

  17. Mantilla CB, Wass CT, Goodrich KA, et al. Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia. Transfusion 2011; 51 (1): 82-91.

  18. Madjdpour C, Heindi V, Spahn DR. Risk, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anesthesiol 2006; 72 (5): 283-98.

  19. Goodnough LT. Anemia, blood transfusion and clinical outcomes in patients with cardiovascular risk factors. Transf Altern Transf Med 2003; 5(3): 352-5.

  20. So-Osman C, Nelissen R, Brand R, Brand A, Stiggelbout AM. Postoperative anemia after joint replacement surgery is not related to quality of life during the first two weeks postoperatively. Transfusion 2011; 51 (1): 71-81.

  21. Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties. Transfusion 2012;52 (2):261-70.

  22. Salido JA, Marin LA, Gómez LA, Zorilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery. J Bone Joint Surg Am 2002; 84-A(2): 216-20.

  23. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of red blood cells. Blood Transf 2009; 7 (1): 49-54.

  24. MacFarland JG. Perioperative blood transfusions. Chest 1999; 115 (Suppl 2): 113S-21S.

  25. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusion: efficacy, risks, alternatives and indications. Br J Anaesth 2005; 95 (1): 33-42.

  26. Johnson P, Wynn-Jones H, Chakravarty D, Boyle A, Parker MJ. Is perioperative blood transfusion a risk factor for mortality or infection after hip fracture?. J Orthop Trauma 2006; 20 (10): 675-9.

  27. Shander A, Fink A, Javidroozi M, Erhard J, Farmer SL, Corwin H et al. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev 2011; 25 (3): 232-46.

  28. Lef Porteous MJ, Miller AJ. Blood transfusion in total hip replacement: is it always necessary? Ann R Coll Surg Engl 1991; 73 (1): 44-5.

  29. Vincent JL. Transfusion triggers: getting it right! Crit Care Med 2012; 40 (12): 3308-9.




2020     |     www.medigraphic.com